Enhabit, Inc. (NYSE:EHAB) Receives Average Recommendation of “Reduce” from Brokerages

Enhabit, Inc. (NYSE:EHAB) has earned a consensus rating of “Reduce” from the seven analysts that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating and six have given a hold rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $9.25.

Separately, Leerink Partners reiterated a “market perform” rating and issued a $8.00 price objective (down from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th.

Enhabit Trading Up 0.9 %

Shares of NYSE:EHAB opened at $7.63 on Tuesday. The company has a market cap of $383.39 million, a PE ratio of -3.33 and a beta of 1.84. The company’s 50-day moving average price is $7.50 and its 200 day moving average price is $8.38. Enhabit has a fifty-two week low of $6.85 and a fifty-two week high of $11.74. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85.

Enhabit (NYSE:EHAB) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.01). The firm had revenue of $253.60 million during the quarter, compared to the consensus estimate of $261.69 million. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. During the same quarter in the prior year, the business earned $0.03 earnings per share. Sell-side analysts anticipate that Enhabit will post 0.22 earnings per share for the current year.

Institutional Trading of Enhabit

Hedge funds and other institutional investors have recently made changes to their positions in the business. FMR LLC raised its holdings in shares of Enhabit by 138.4% in the 3rd quarter. FMR LLC now owns 3,388 shares of the company’s stock worth $27,000 after purchasing an additional 1,967 shares in the last quarter. Gladius Capital Management LP bought a new stake in shares of Enhabit in the 2nd quarter worth approximately $31,000. Quarry LP raised its holdings in shares of Enhabit by 242.2% in the 2nd quarter. Quarry LP now owns 3,703 shares of the company’s stock worth $33,000 after purchasing an additional 2,621 shares in the last quarter. Allspring Global Investments Holdings LLC bought a new stake in shares of Enhabit in the 1st quarter worth approximately $44,000. Finally, Stoneridge Investment Partners LLC purchased a new position in shares of Enhabit in the third quarter worth approximately $81,000.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.